API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-21-2018-1542783991.pdf
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=812201872739
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204688
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203960
http://nordiclifescience.org/sobi-gains-commercial-rights-pharma-swiss/
http://www.prnewswire.com/news-releases/twi-pharmaceuticals-inc-receives-favorable-decision-from-the-us-court-of-appeals-for-the-federal-circuit-regarding-twis-generic-version-of-megace-esr-625mg5ml-300193628.html
http://www.news-medical.net/news/20150729/TWi-releases-generic-version-of-MEGACE-ES-(megestrol-acetate-oral-suspension)-625mg5ml.aspx?utm_source=twitterfeed&utm_medium=twitter&utm_campaign=DTN+Pharma+News:
http://indianexpress.com/article/india/india-others/12-cancer-drugs-may-come-under-price-control/